P1: PSB Printer: Yet To Come
9780521704632c22 CUFX213A/Peck 9780521618168 December 29, 2007 14:51
Section IVOther important drugs
been reported after prolonged treatment, especially from heart valve vegetations,
and fungal endocarditis normally requires surgical intervention to cure.
Mechanism of action
Amphotericin reacts withergosterol in the fungal cell membrane, creating pores
through which cell contents are lost. It reacts less withcholesterol and is not as toxic
to human cells. As the dose is increased, the pore size created increases and cell
damage occurs at a faster rate.
Kinetics
Amphotericin is only administered parenterally and is highly plasma protein bound.
Tissue penetration is poor and negligible levels are found in CSF or urine. It appears
to be metabolized by the liver and plasma levels do not rise in renal failure. However,
due to its potential for nephrotoxicity, dose reduction is still considered in renally
impaired patients. Liposomal preparations are available that allow higher doses to
be given with less renal toxicity – they are considerably more expensive.
Side effects
Renal – renal impairment is only reversible if treatment is stopped early. Renal
toxicity can be limited if the dose is gradually increased over the first 48 hours.
Miscellaneous – it may cause any of the following: gastrointestinal upsets, blood
dyscrasias, febrile reactions, muscle pains, visual and hearing disturbances, con-
vulsions, anaphylaxis and altered liver function tests. Some of these effects can be
ameliorated by reducing the rate of administration or by the co-administration of
steroids or antihistamines.
Azoles
This category can be further subdivided into triazoles (fluconazole and itraconazole)
and imidazoles (ketoconazole and miconazole). They are active against a wide range
of fungi and yeasts includingCandidaspp.,Coccidioidesspp.,Cryptococcusspp. and
Histoplasmaspp. Itraconazole and miconazole also coverAspergillusspp. infection.
Resistance is rarely problematic but isolates are known to demonstrate resistance to
more than one agent.
Mechanism of action
These agents all work by disrupting ergosterol synthesis. The blockade of 14-α
demethylation during ergosterol manufacture leads to an alteration in membrane
function. Higher concentrations of azoles also damage ergosterol directly leading to
loss of membrane integrity, cell leakage and death.